| |
| |
|
| Insider
Information: |
Ando Dale G |
| Relationship: |
VP, Therapeutic Dev. &... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
107,328 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$56,240 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
107,328 |
|
|
| Total
Value |
$56,240 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sangamo Biosciences Inc |
SGMO |
VP, Therapeutic Dev. &... |
2015-12-12 |
107,328 |
2011-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-12-12 |
4 |
D |
$8.68 |
$34,720 |
D/D |
(4,000) |
107,328 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-12-11 |
4 |
D |
$8.68 |
$37,741 |
D/D |
(4,348) |
111,328 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
121,763 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-12-07 |
4 |
D |
$9.69 |
$58,983 |
D/D |
(6,087) |
115,676 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-06-05 |
4 |
OE |
$3.45 |
$51,750 |
D/D |
15,000 |
111,763 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-06-05 |
4 |
AS |
$12.29 |
$184,394 |
D/D |
(15,000) |
96,763 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-05-05 |
4 |
AS |
$12.29 |
$184,298 |
D/D |
(15,000) |
95,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-05-05 |
4 |
OE |
$3.45 |
$51,750 |
D/D |
15,000 |
110,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-04-06 |
4 |
AS |
$14.94 |
$224,172 |
D/D |
(15,000) |
95,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-04-06 |
4 |
OE |
$3.45 |
$51,750 |
D/D |
15,000 |
110,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-03-05 |
4 |
OE |
$3.45 |
$51,750 |
D/D |
15,000 |
110,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-03-05 |
4 |
AS |
$18.29 |
$274,283 |
D/D |
(15,000) |
95,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-02-05 |
4 |
AS |
$12.93 |
$193,950 |
D/D |
(15,000) |
95,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-02-05 |
4 |
OE |
$3.45 |
$91,509 |
D/D |
15,000 |
110,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-01-05 |
4 |
AS |
$15.17 |
$227,854 |
D/D |
(15,000) |
95,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2015-01-05 |
4 |
OE |
$6.82 |
$102,300 |
D/D |
15,000 |
110,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-12-15 |
4 |
D |
$14.74 |
$405,006 |
D/D |
(27,480) |
95,376 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
122,856 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-12-05 |
4 |
AS |
$11.21 |
$168,197 |
D/D |
(15,000) |
97,856 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-12-05 |
4 |
OE |
$6.82 |
$102,300 |
D/D |
15,000 |
112,856 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-11-05 |
4 |
OE |
$4.11 |
$83,877 |
D/D |
15,000 |
112,856 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-11-05 |
4 |
AS |
$11.35 |
$170,258 |
D/D |
(15,000) |
97,856 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-10-06 |
4 |
AS |
$10.72 |
$160,865 |
D/D |
(15,000) |
96,579 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-10-06 |
4 |
OE |
$4.11 |
$61,650 |
D/D |
15,000 |
111,579 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Therapeutic Dev. & CMO |
• – – |
2014-09-05 |
4 |
AS |
$12.20 |
$183,072 |
D/D |
(15,000) |
96,579 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
